Original Literature | Model OverView |
---|---|
Publication
Title
The role of the interferon regulatory factor (IRF) family in dendritic celldevelopment and function.
Affiliation
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita,Viale Regina Elena 299, 00161 Roma, Italy. lucia.gabriele@iss.it
Abstract
Dendritic cells (DCs) are powerful sensors of foreign pathogens as well ascancer cells and provide the first line of defence against infection. They alsoserve as a major link between innate and adaptive immunity. Immature DCs respondto incoming danger signals and undergo maturation to produce high levels ofproinflammatory cytokines including type I interferons (IFNs) to establishinnate immunity. They then present antigens to T lymphocytes to stimulatelasting specific immune responses. Recent studies point to the importance of DCsin the induction of peripheral tolerance. Transcription factors of the IRFfamily have emerged as crucial controllers of many aspects of DC activity,playing an essential role in the establishment of early innate immunity.Furthermore, eight of the nine members of the IRF family have been shown tocontrol either the differentiation and/or the functional activities of DCs. Inthis review, we focus on three aspects of DC properties that are under thecontrol of IRFs: (1) the development and differentiation, (2) maturation inresponse to toll-like receptor (TLR) signalling and the production ofanti-microbial cytokines, and (3) activation and expansion of lymphocytes togenerate protective or tolerogenic immune responses.
PMID
17702640
|
Entity
Process
IFN-beta
--
G010228
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93217
10
infinite
0
TRANSFAC | G010228 |
--
IL-12 p40
--
G010657
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93589
10
infinite
0
TRANSFAC | G010657 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IRAK-1
--
MO000000213
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m184
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000213 |
--
IKK
--
MO000000248
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m207
10
infinite
0
TRANSPATH | MO000000248 |
--
AP-1
--
MO000000276
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m219
10
infinite
0
TRANSPATH | MO000000276 |
--
IRF-8
--
MO000007185
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m769
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007185 |
--
IRF-1
--
MO000007685
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m970
10
infinite
0
InterPro | IPR001346 |
TRANSPATH | MO000007685 |
--
IRF-4
--
MO000007697
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m978
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007697 |
--
IRF-5
--
MO000007700
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m979
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
IKK-i {activated}
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
IFN Type I
--
MO000016658
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1634
10
infinite
0
TRANSPATH | MO000016658 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
IL-12
--
MO000017265
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2121
10
infinite
0
TRANSPATH | MO000017265 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
cytokines
--
MO000019387
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3957
10
infinite
0
TRANSPATH | MO000019387 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
IFNalpha, IFNbeta
--
MO000038482
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m16692
10
infinite
0
TRANSPATH | MO000038482 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
IRF-3{p}
--
MO000041456
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19324
10
infinite
0
TRANSPATH | MO000041456 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IRF-4: PU.1
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
IRF-8: PU.1
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
IRF-1: IRF-8
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
FLT3L: FLT3
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m15
0
infinite
0
--
GM-CSF: GM-CSF
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m16
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m17
0
infinite
0
--
--
e17
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m18
0
infinite
0
--
--
e18
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m19
0
infinite
0
--
STAT3 {activated}
--
e19
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m20
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CD14: MD-2: TLR4
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
NF-kappaB {activated}
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
TRANSPATH | MO000000058 |
--
1,25(OH)2D3
--
e22
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
ssRNA: TLR7
--
e23
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m24
0
infinite
0
--
ssRNA: TLR8
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
CpG DNA: TLR9
--
e25
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m26
0
infinite
0
--
TLR ligand
--
e26
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m27
0
infinite
0
--
TLR liagnd: TLRs
--
e27
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m28
0
infinite
0
--
IFN- Type I
--
e28
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m29
0
infinite
0
--
cytokines
--
e29
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
MHC antigen
--
e30
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m31
0
infinite
0
--
TLR2 ligand : TLR2
--
e31
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
TLR3 ligand: TLR3
--
e34
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m35
0
infinite
0
--
LPS: CD14: MD-2: TLR4
--
e35
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m36
0
infinite
0
--
ssRNA
--
e36
cso30:c:Rna
cso30:i:CC_Extracellular
--
csml-variable:Double
m37
0
infinite
0
--
CpG DNA
--
e37
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m38
0
infinite
0
--
ssRNA: TLR7: MyD88
--
e38
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m39
0
infinite
0
--
ssRNA: TLR8: MyD88
--
e39
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
CpG DNA: TLR9: MyD88
--
e40
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m41
0
infinite
0
--
ssRNA: TLR7: MyD88: IRAK-1: IRAK-4: TRAF6: IRF-7
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
ssRNA: TLR8: MyD88: IRAK-1: IRAK-4: TRAF6: IRF-7
--
e42
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m43
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1: IRAK-4: TRAF6: IRF-7
--
e43
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m44
0
infinite
0
--
IKK [activated}
--
e44
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m45
10
infinite
0
TRANSPATH | MO000000248 |
--
IRF7: IRF-7
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
IRF7: IRF-7
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
NF-kappaB {nucleus}
--
e48
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m49
10
infinite
0
TRANSPATH | MO000000058 |
--
IFN-alpha4
--
e49
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m63
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
RIG-1
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
LPS: CD14: MD-2: TLR4: MyD88: TIRAP
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m64
0
infinite
0
--
LPS: CD14: MD-2: TLR4: TRAM: TRIF
--
e64
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
LPS: CD14: MD-2: TLR4: TRAM: TRIF: TRAF3: NAP1
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
10
infinite
0
Affymetrix | 1452196_a_at |
Ensembl | ENSMUSG00000027002 |
MGD | Nckap1 |
Proteome | HumanPSD/Nckap1 |
RefSeq | NM_016965 |
TRANSPATH | MO000079906 |
Unigene | Mm.25203 |
UniProt | P28660 |
--
TLR3 ligand: TLR3: TRIF: TRAF3: NAP1
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
TBK1 {activated}
--
e68
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
IRF-5 {activated}
--
e69
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m70
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
MyD88: IRF-4
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
ssRNA: TLR7: MyD88: IRAK-1: IRAK-4: TRAF6: IRF-7: IRF-5
--
e71
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m72
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1: IRAK-4: TRAF6: IRF-7: IRF-5
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
LPS: CD14: MD-2: TLR4: MyD88: TIRAP: IRF-5
--
e73
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m74
0
infinite
0
--
Mda-5
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
LGP2
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
IL-12p35
--
e77
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m78
0
infinite
0
--
IPS-1
--
e78
cso30:c:Protein
cso30:i:CC_MitochondrialMatrix
--
csml-variable:Double
m79
0
infinite
0
--
IPS-1 {activated}
--
e79
cso30:c:Protein
cso30:i:CC_MitochondrialMatrix
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
dsRNA: LGP2
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
csml-variable:Double
m86
0
infinite
0
--
csml-variable:Double
m87
0
infinite
0
--
ssRNA: TLR7: MyD88: IRAK-1: IRAK-4: TRAF6
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m89
0
infinite
0
--
ssRNA: TLR8: MyD88: IRAK-1: IRAK-4: TRAF6
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1: IRAK-4: TRAF6
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m978*m15836*0.1
nodelay
--
0
PMID: 17702640, 11846986 They are expressed preferentially in hematopoietic cells, of both myeloid and lymphoid origin, and interact with the same partner transcription factors such as PU.1, an immune cell specific protein of the Ets family, although the two factors associate with distinct factors as well.
p10
p10
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c27 : 1
m155666*0.1
nodelay
--
0
PMID: 17702640 IRF-8-KO DCs generated in presence of Flt3L are impaired in maturation, unlike wild type DCs that give rise to mature DCs capable of producing IL-12p40 and expressing CD8¦Á in response to LPS.
p100
p100
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c295 : 1
stoichiometry:c298 : 1
stoichiometry:c300 : 1
stoichiometry:c301 : 1
stoichiometry:c296 : 1
m980*m80*m69*m1599*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
p101
p101
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c310 : 1
stoichiometry:c304 : 1
m3902*m80*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway.
p102
p102
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c305 : 1
stoichiometry:c307 : 1
stoichiometry:c308 : 1
stoichiometry:c309 : 1
stoichiometry:c312 : 1
stoichiometry:c314 : 1
stoichiometry:c306 : 1
m84*m1814*m83*m80*m22*m219*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c315 : 1
stoichiometry:c316 : 1
m82*0.1
nodelay
--
0
PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c290 : 1
stoichiometry:c319 : 1
stoichiometry:c320 : 1
m119368*m76*0.1
nodelay
--
0
PMID: 17702640 RNA helicases that recognize dsRNA also stimulate activation of IRF-3/7 leading to IFNbeta induction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c291 : 1
stoichiometry:c323 : 1
stoichiometry:c322 : 1
m119368*m6*0.1
nodelay
--
0
PMID: 17702640 RNA helicases that recognize dsRNA also stimulate activation of IRF-3/7 leading to IFNbeta induction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c292 : 1
stoichiometry:c324 : 1
stoichiometry:c325 : 1
m119368*m77*0.1
nodelay
--
0
PMID: 17702640 RNA helicases that recognize dsRNA also stimulate activation of IRF-3/7 leading to IFNbeta induction.
p11
p11
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m15*m1360*0.1
nodelay
--
0
PMID: 17702640, 16474425, 14670306 As STAT-3 is required for Flt3L-dependent differentiation of pDCs and CD8¦Á+ DCs, it may be suggested that IRF-8, acting downstream of the Flt3L/STAT3 pathway, specifically regulates the differentiation of these DC subsets.
p12
p12
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c195 : 1
stoichiometry:c197 : 1
m769*m29*0.1
nodelay
--
0
PMID: 17702640 Interestingly, our evidence indicates that not only IRF-3/7, IRF-8 plays a critical role in the production of type I IFNs both in pDCs and cDCs.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c37 : 1
stoichiometry:c36 : 1
m14*m16*0.1
nodelay
--
0
PMID: 17702640, 16272311 Consistent with this finding, it has been reported that this growth factor specifically stimulates IRF-4 expression in human monocytes-derived DCs through the activation of NF-kappaB.
p14
p14
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c41 : 1
stoichiometry:c39 : 1
m49*0.1
nodelay
--
0
PMID: 17702640, 16272311 Consistent with this finding, it has been reported that this growth factor specifically stimulates IRF-4 expression in human monocytes-derived DCs through the activation of NF-kappaB. PMID: 17702640, 15829558 Moreover, 1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3), a potent inhibitor of DC differentiation, completely abolishes in vitro-induced up-regulation of IRF-4 in monocytes-derived DCs and blood mDCs but not in pDCs.
p15
p15
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c43 : 1
m970*0.1
nodelay
--
0
PMID: 17702640 In addition, IRF-1, like IRF-8 positively regulates the expression of some proinflammatory cytokines, such as IL-12p40.
p16
p16
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c44 : 1
m769*0.1
nodelay
--
0
PMID: 17702640 In addition, IRF-1, like IRF-8 positively regulates the expression of some proinflammatory cytokines, such as IL-12p40.
p17
p17
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m155666*m769*0.1
nodelay
--
0
PMID: 17702640, 16339401 Intriguingly, IRF-8 has been shown to be required for the induction of the enzyme indoleamine 2,3-dioxygenase, an essential component of the tolerogenic program of murine CD8¦Á+ DCs and LPS-stimulated, monocyte-derived human DCs.
p18
p18
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c47 : 1
stoichiometry:c51 : 1
stoichiometry:c50 : 1
m155666*m769*m93417*0.1
nodelay
--
0
PMID: 17702640, 16339401 Intriguingly, IRF-8 has been shown to be required for the induction of the enzyme indoleamine 2,3-dioxygenase, an essential component of the tolerogenic program of murine CD8¦Á+ DCs and LPS-stimulated, monocyte-derived human DCs.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m769*m970*0.1
nodelay
--
0
PMID: 17702640, 16597464 This finding mirrors the ability of IRF-1 and IRF-8 to form heterocomplexes and cooperatively regulate the expression of many genes involved in the onset of innate immunity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m769*m15836*0.1
nodelay
--
0
PMID: 17702640, 11846986 They are expressed preferentially in hematopoietic cells, of both myeloid and lymphoid origin, and interact with the same partner transcription factors such as PU.1, an immune cell specific protein of the Ets family, although the two factors associate with distinct factors as well.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m27*m3962*0.1
nodelay
--
0
PMID: 17702640 Upon recognition of microbial components, TLRs trigger a cascade of signalling events leading to inflammatory responses through the production of a variety of cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c59 : 1
m29*m28*0.1
nodelay
--
0
PMID: 17702640, 17113765 Type I IFNs are the major cytokines that confer early protection against incoming pathogens, as they broadly elicit anti-viral and anti-microbial agents.
p22
p22
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c65 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640 Type I IFN also stimulates DC maturation by increasing expression of the costimulatory molecules such as CD80, CD86, CD40 and the major histocompatibility complex antigens.
p23
p23
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c66 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640 Type I IFN also stimulates DC maturation by increasing expression of the costimulatory molecules such as CD80, CD86, CD40 and the major histocompatibility complex antigens.
p24
p24
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c67 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640 Type I IFN also stimulates DC maturation by increasing expression of the costimulatory molecules such as CD80, CD86, CD40 and the major histocompatibility complex antigens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c69 : 1
m28*0.1
nodelay
--
0
PMID: 17702640 Upon recognition of microbial components, TLRs trigger a cascade of signalling events leading to inflammatory responses through the production of a variety of cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c70 : 1
m30*m28*0.1
nodelay
--
0
PMID: 17702640 Upon recognition of microbial components, TLRs trigger a cascade of signalling events leading to inflammatory responses through the production of a variety of cytokines.
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640 Type I IFN also stimulates DC maturation by increasing expression of the costimulatory molecules such as CD80, CD86, CD40 and the major histocompatibility complex antigens.
p28
p28
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m95018*m93745*m93612*m31*0.1
nodelay
--
0
PMID: 17702640 Type I IFN also stimulates DC maturation by increasing expression of the costimulatory molecules such as CD80, CD86, CD40 and the major histocompatibility complex antigens.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m33*m3964*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
p3
p3
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c55 : 1
stoichiometry:c68 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c40 : 1
m11*m12*m974*m769*m20*0.1
nodelay
--
0
PMID: 17702640, 16966383 In the past few years IRF-4 and IRF-8 first, and IRF-1 next, have emerged as key players of DC development. PMID: 17702640, 16474425, 14670306 As STAT-3 is required for Flt3L-dependent differentiation of pDCs and CD8¦Á+ DCs, it may be suggested that IRF-8, acting downstream of the Flt3L/STAT3 pathway, specifically regulates the differentiation of these DC subsets. PMID: 17702640, 15829558 Moreover, 1alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3), a potent inhibitor of DC differentiation, completely abolishes in vitro-induced up-regulation of IRF-4 in monocytes-derived DCs and blood mDCs but not in pDCs. PMID: 17702640, 16172134 Moreover, at variance with IRF-4, IRF-1 appears to function as a negative regulator of CD4+CD8¦Á¡Ý DC differentiation. In support of this finding, IRF-4 is shown to be a natural antagonist of IRF-1 in immune cells including DCs. PMID: 17702640, 17018853, 10891453 Thus, in accordance with the reports indicating that IFNalpha/beta exert an inhibitory effect on human DC maturation [33] and [34], IRF-2 may protect developing DCs, especially myeloid lineage-related subsets, from detrimental effects of high levels of IFNalpha/beta such as maturation arrest.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m34*m3965*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c202 : 1
stoichiometry:c91 : 1
m155666*m21*0.1
nodelay
--
0
PMID: 17702640 Upon LPS ligation, TLR4, which forms a receptor complex with CD14 and MD-2, signals through the adaptors TIRAP and MyD88 as well as Trif and TRAM.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c94 : 1
stoichiometry:c97 : 1
m37*m19940*0.1
nodelay
--
0
PMID: 17702640, 15829275 TLR7/8 and TLR9 recognize viral single-stranded RNA and double-stranded CpG-rich DNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m37*m19823*0.1
nodelay
--
0
PMID: 17702640, 15829275 TLR7/8 and TLR9 recognize viral single-stranded RNA and double-stranded CpG-rich DNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m38*m19828*0.1
nodelay
--
0
PMID: 17702640, 15829275 TLR7/8 and TLR9 recognize viral single-stranded RNA and double-stranded CpG-rich DNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m24*m1572*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m25*m1572*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m26*m1572*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
p38
p38
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c117 : 1
stoichiometry:c120 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m184*m17258*m183*m980*m40*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
p39
p39
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c116 : 1
stoichiometry:c119 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m184*m17258*m183*m980*m39*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
p4
p4
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c10 : 1
m155666*0.1
nodelay
--
0
PMID: 17702640 Of note, the entire splenic DC population from IRF-1 KO mice fail to undergo maturation in response to viral or bacterial stimuli, such as New Castle disease (NDV) virus and LPS, and express high levels of tolerogenic cytokines such as IL-10, accounting for the induction of suppressor activity in allogeneic CD4+CD25+ regulatory T (Treg) cells.
p40
p40
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c118 : 1
stoichiometry:c121 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m184*m17258*m183*m980*m41*0.1
nodelay
--
0
PMID: 17702640 Upon ligand binding, TLR7/8 and TLR9 signal through the cytoplasm adaptor MyD88 and form a signalling complex with members of the IL-1 receptor-associated kinase (IRAK1 and IRAK4), TRAF6 and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c128 : 1
m36*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c129 : 1
m35*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c130 : 1
m32*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
p44
p44
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c140 : 1
stoichiometry:c134 : 1
m93589*m36*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
p45
p45
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c141 : 1
stoichiometry:c135 : 1
m93589*m35*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
p46
p46
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c142 : 1
stoichiometry:c136 : 1
m93589*m32*0.1
nodelay
--
0
PMID: 17702640, 15976491 Both human mDCs and mouse cDCs express TLR2, TLR3, and TLR4 and produce IL-12 upon receptor engagement.
p47
p47
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c151 : 1
stoichiometry:c146 : 1
m48*m219*m49*0.1
nodelay
--
0
PMID: 17702640, 11592079, 15771572 Being the main TLRs expressed in the endosomal compartments of pDCs, TLR7/8 and TLR9 are involved in the recognition of viruses and bacteria and production of type I IFNs in both species although in the mouse they can also produce IL-12. PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs.
p48
p48
cso30:i:ME_Translocation
cso30:i:CC_NuclearEnvelopeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m22*0.1
nodelay
--
0
PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c183 : 1
stoichiometry:c187 : 1
m48*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m632*m63933*0.1
nodelay
--
0
PMID: 17702640 The Flt3 ligand (Flt3L) expands preferentially pDCs and CD8¦Á+ DCs, in which IRF-8 expression is predominant.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c155 : 1
stoichiometry:c143 : 1
m44*m29*0.1
nodelay
--
0
PMID: 17702640, 11592079, 15771572 Being the main TLRs expressed in the endosomal compartments of pDCs, TLR7/8 and TLR9 are involved in the recognition of viruses and bacteria and production of type I IFNs in both species although in the mouse they can also produce IL-12.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c156 : 1
stoichiometry:c144 : 1
m43*m29*0.1
nodelay
--
0
PMID: 17702640, 11592079, 15771572 Being the main TLRs expressed in the endosomal compartments of pDCs, TLR7/8 and TLR9 are involved in the recognition of viruses and bacteria and production of type I IFNs in both species although in the mouse they can also produce IL-12.
p52
p52
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c157 : 1
stoichiometry:c253 : 1
stoichiometry:c145 : 1
m42*m29*m70*0.1
nodelay
--
0
PMID: 17702640, 11592079, 15771572 Being the main TLRs expressed in the endosomal compartments of pDCs, TLR7/8 and TLR9 are involved in the recognition of viruses and bacteria and production of type I IFNs in both species although in the mouse they can also produce IL-12. PMID: 17702640, 15695821 Given the evidence that human IRF-5 selectively regulates TLR7-mediated type I IFN induction, IRF-5 may play a species-specific function.
p53
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c172 : 1
stoichiometry:c159 : 1
m207*m42*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40.
p54
p54
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c171 : 1
stoichiometry:c161 : 1
m207*m43*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40.
p55
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c170 : 1
stoichiometry:c163 : 1
m207*m44*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40.
p56
p56
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c318 : 1
stoichiometry:c62 : 1
m45*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40. PMID: 17702640, 16243976 Lastly, a recent report shows that IRF-4 negatively regulates production of proinflammatory cytokines such as IL-6 and TNFalpha in response to TLR stimulation, suggesting that this factor prevents harmful effects of endotoxin and curtails excess inflammatory responses.
p57
p57
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c317 : 1
stoichiometry:c63 : 1
m45*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40. PMID: 17702640, 16243976 Lastly, a recent report shows that IRF-4 negatively regulates production of proinflammatory cytokines such as IL-6 and TNFalpha in response to TLR stimulation, suggesting that this factor prevents harmful effects of endotoxin and curtails excess inflammatory responses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c64 : 1
m45*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m45*0.1
nodelay
--
0
PMID: 17702640, 17276695 TRAF-6 activates a canonical IKK-mediated pathway which culminates in the induction of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, IL-6, IL-1beta and IL-12p40.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c20 : 1
m15*m16*0.1
nodelay
--
0
PMID: 17702640 The Flt3 ligand (Flt3L) expands preferentially pDCs and CD8¦Á+ DCs, in which IRF-8 expression is predominant. PMID: 17702640 Thus, the differentiation and functions of Flt3L-induced DC subsets depend on IRF-8 activity. PMID: 17702640, 15728463 Whereas, GM-CSF selectively promotes the differentiation of CD8¦Á¡Ý DCs that predominantly express IRF-4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c175 : 1
stoichiometry:c328 : 1
m42*0.1
nodelay
--
0
PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c176 : 1
stoichiometry:c178 : 1
m43*0.1
nodelay
--
0
PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c177 : 1
stoichiometry:c179 : 1
m44*0.1
nodelay
--
0
PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
m46*0.1
nodelay
--
0
PMID: 17702640, 15361868 Alternatively, following phosphorylation by IRAK1 and activation by TRAF-dependent ubiquitination, IRF-7 dimerizes and translocates into the nucleus where together with NF-kappaB and AP-1 regulates expression of type I IFNs. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
p64
p64
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c188 : 1
m19324*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner. PMID: 17702640 Similarly, TLR3 transmits signals through Trif to activate IRF-3, which then mediates primary IFNbeta and IFN-alpha4 induction. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
p65
p65
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c332 : 1
stoichiometry:c189 : 1
m48*m970*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes. PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
p66
p66
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c330 : 1
stoichiometry:c190 : 1
m19324*m970*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner. PMID: 17702640 Similarly, TLR3 transmits signals through Trif to activate IRF-3, which then mediates primary IFNbeta and IFN-alpha4 induction. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes. PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c191 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner.
p68
p68
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c192 : 1
m1634*0.1
nodelay
--
0
PMID: 17702640, 17113765, 16474425, 12702806 Previous studies in non-DC cell types have shown that IFN production involves two steps, an initial induction of IFN¦Â and IFN¦Á4 though IRF-3 and IRF-7 activation, leading to the second phase where additional IFNalpha genes and IRF-7 are induced in a IFN-dependent manner.
p69
p69
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c196 : 1
m769*0.1
nodelay
--
0
PMID: 17702640 Interestingly, our evidence indicates that not only IRF-3/7, IRF-8 plays a critical role in the production of type I IFNs both in pDCs and cDCs.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m88*m81*0.1
nodelay
--
0
PMID: 17702640, 15728463 Whereas, GM-CSF selectively promotes the differentiation of CD8¦Á¡Ý DCs that predominantly express IRF-4.
PMID: 17702640, 15711573 TLR3-mediated signalling triggers the maturation of immature CD8¦Á+ DCs that become competent to mediate cross-priming of T cells.
p71
p71
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c199 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m3961*m6438*m2828*0.1
nodelay
--
0
PMID: 17702640 Upon LPS ligation, TLR4, which forms a receptor complex with CD14 and MD-2, signals through the adaptors TIRAP and MyD88 as well as Trif and TRAM.
p72
p72
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c206 : 1
stoichiometry:c205 : 1
m6810*m36*m1572*0.1
nodelay
--
0
PMID: 17702640 Upon LPS ligation, TLR4, which forms a receptor complex with CD14 and MD-2, signals through the adaptors TIRAP and MyD88 as well as Trif and TRAM.
p73
p73
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c210 : 1
m19005*m18998*m36*0.1
nodelay
--
0
PMID: 17702640 Upon LPS ligation, TLR4, which forms a receptor complex with CD14 and MD-2, signals through the adaptors TIRAP and MyD88 as well as Trif and TRAM.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c225 : 1
stoichiometry:c226 : 1
m67*m65*m1872*0.1
nodelay
--
0
PMID: 17702640 In particular, Trif interacts with TRAF3 and NAP1 and together cooperate to activate TBK1, which in turn mediates the phosphorylation of IRF-3.
p75
p75
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c213 : 1
stoichiometry:c217 : 1
m18998*m67*m35*m1872*0.1
nodelay
--
0
PMID: 17702640 In particular, Trif interacts with TRAF3 and NAP1 and together cooperate to activate TBK1, which in turn mediates the phosphorylation of IRF-3.
p76
p76
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c220 : 1
stoichiometry:c219 : 1
m3902*m68*0.1
nodelay
--
0
PMID: 17702640 In particular, Trif interacts with TRAF3 and NAP1 and together cooperate to activate TBK1, which in turn mediates the phosphorylation of IRF-3.
p77
p77
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
stoichiometry:c222 : 1
m977*m69*m65*0.1
nodelay
--
0
PMID: 17702640 The latter two molecules mediate the activation of IRF-3. PMID: 17702640 In particular, Trif interacts with TRAF3 and NAP1 and together cooperate to activate TBK1, which in turn mediates the phosphorylation of IRF-3.
p78
p78
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c229 : 1
stoichiometry:c228 : 1
m3902*m66*0.1
nodelay
--
0
PMID: 17702640 In particular, Trif interacts with TRAF3 and NAP1 and together cooperate to activate TBK1, which in turn mediates the phosphorylation of IRF-3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c230 : 1
m93217*0.1
nodelay
--
0
PMID: 17702640 The secreted IFNs, particularly IFNb, stimulate the expression of IFN-inducible genes including IRF-7.
p8
p8
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c26 : 1
stoichiometry:c22 : 1
m93589*m155666*0.1
nodelay
--
0
PMID: 17702640 IRF-8-KO DCs generated in presence of Flt3L are impaired in maturation, unlike wild type DCs that give rise to mature DCs capable of producing IL-12p40 and expressing CD8¦Á in response to LPS.
p80
p80
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c242 : 1
stoichiometry:c232 : 1
m36*m970*0.1
nodelay
--
0
PMID: 17702640 TLR4 is expressed on the plasma membrane and is the only receptor that can mediate the induction of IFNbeta, but not IFNalpha, upon recognition of non-nucleic acid ligands such as LPS. PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c235 : 1
stoichiometry:c180 : 1
m74*0.1
nodelay
--
0
PMID: 17702640, 15665823 It has recently been reported that another member of IRF family, namely IRF-5, participates in cytokine gene expression in response to TLR7, TLR9 and TLR4 via MyD88-dependent signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c237 : 1
stoichiometry:c240 : 1
m72*0.1
nodelay
--
0
PMID: 17702640, 15665823 It has recently been reported that another member of IRF family, namely IRF-5, participates in cytokine gene expression in response to TLR7, TLR9 and TLR4 via MyD88-dependent signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c239 : 1
stoichiometry:c329 : 1
m73*0.1
nodelay
--
0
PMID: 17702640, 15665823 It has recently been reported that another member of IRF family, namely IRF-5, participates in cytokine gene expression in response to TLR7, TLR9 and TLR4 via MyD88-dependent signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c243 : 1
m70*0.1
nodelay
--
0
PMID: 17702640, 15665823 It has recently been reported that another member of IRF family, namely IRF-5, participates in cytokine gene expression in response to TLR7, TLR9 and TLR4 via MyD88-dependent signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c245 : 1
stoichiometry:c246 : 1
stoichiometry:c244 : 1
m30*m70*0.1
nodelay
--
0
PMID: 17702640, 15665823 It has recently been reported that another member of IRF family, namely IRF-5, participates in cytokine gene expression in response to TLR7, TLR9 and TLR4 via MyD88-dependent signalling.
p86
p86
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c248 : 1
stoichiometry:c250 : 1
stoichiometry:c251 : 1
stoichiometry:c252 : 1
stoichiometry:c249 : 1
m979*m68*m69*m1599*0.1
nodelay
--
0
PMID: 17702640, 16751392 Moreover, IRF-5 is shown to be essential for TLR3 signalling, which does not utilize MyD88. A recent report indicates that IRF-5 is activated when TBK1 or IKKi/epsilon is coexpressed.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c256 : 1
stoichiometry:c254 : 1
m42*m70*0.1
nodelay
--
0
PMID: 17702640, 15695821 Given the evidence that human IRF-5 selectively regulates TLR7-mediated type I IFN induction, IRF-5 may play a species-specific function.
p88
p88
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c258 : 1
stoichiometry:c259 : 1
m1572*m978*0.1
nodelay
--
0
PMID: 17702640, 16236719 In this context, IRF-4 has been shown to form a complex with MyD88 to compete with IRF-5.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c261 : 1
stoichiometry:c265 : 1
stoichiometry:c262 : 1
m979*m42*0.1
nodelay
--
0
PMID: 17702640, 16236719 In this context, IRF-4 has been shown to form a complex with MyD88 to compete with IRF-5.
p9
p9
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c23 : 1
m155666*0.1
nodelay
--
0
PMID: 17702640 IRF-8-KO DCs generated in presence of Flt3L are impaired in maturation, unlike wild type DCs that give rise to mature DCs capable of producing IL-12p40 and expressing CD8¦Á in response to LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c263 : 1
stoichiometry:c264 : 1
stoichiometry:c266 : 1
stoichiometry:c241 : 1
m979*m44*0.1
nodelay
--
0
PMID: 17702640, 16236719 In this context, IRF-4 has been shown to form a complex with MyD88 to compete with IRF-5.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c267 : 1
stoichiometry:c270 : 1
stoichiometry:c268 : 1
m979*m64*0.1
nodelay
--
0
PMID: 17702640, 16236719 In this context, IRF-4 has been shown to form a complex with MyD88 to compete with IRF-5.
p92
p92
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearEnvelopeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c284 : 1
stoichiometry:c272 : 1
stoichiometry:c274 : 1
stoichiometry:c271 : 1
m93217*m970*m26*0.1
nodelay
--
0
PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
p93
p93
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c279 : 1
stoichiometry:c278 : 1
m1639*0.1
nodelay
--
0
PMID: 17702640 In addition, pre-treatment of DCs with IFN-gamma, a strong inducer of IRF-1, leads to a robust IFNbeta induction upon CpG-B treatment.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c288 : 1
stoichiometry:c321 : 1
stoichiometry:c289 : 1
m79*m87*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway.
p95
p95
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c285 : 1
stoichiometry:c273 : 1
stoichiometry:c275 : 1
stoichiometry:c277 : 1
m93217*m970*m26*0.1
nodelay
--
0
PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
p96
p96
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c283 : 1
stoichiometry:c286 : 1
stoichiometry:c331 : 1
stoichiometry:c281 : 1
m1639*m26*m970*0.1
nodelay
--
0
PMID: 17702640 In addition, pre-treatment of DCs with IFN-gamma, a strong inducer of IRF-1, leads to a robust IFNbeta induction upon CpG-B treatment. PMID: 17702640 It has been reported that IRF-1-KO GM-CSF-derived BM DCs are unable to induce IFNbeta, inducible nitric-oxide synthase, and IL-12p35 following CpG-A stimulation, despite that IRF-1 KO pDCs exhibit normal type I IFN gene induction upon CpG-B stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c282 : 1
stoichiometry:c326 : 1
stoichiometry:c287 : 1
m79*m86*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c276 : 1
stoichiometry:c327 : 1
stoichiometry:c280 : 1
m79*m85*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway.
p99
p99
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c293 : 1
stoichiometry:c297 : 1
stoichiometry:c299 : 1
stoichiometry:c302 : 1
stoichiometry:c294 : 1
m977*m80*m69*m1599*0.1
nodelay
--
0
PMID: 17702640 These properties relate to the fact that DCs express RNA helicases, RIG-1, Mda5 and LGP2, cytoplasmic proteins capable of detecting actively replicating viruses. Though the CARD domain these helicases signal to the adaptor IFNbeta promoter stimulator 1 (IPS-1), which localizes in mitochondria and mediate the activation of IRF-3 and IRF-7 through a TBK1-IKKi/epsilon-dependent pathway. PMID: 17702640, 16979567 These factors, together with NF-kappaB and AP-1 activated by IPS-1 via FADD/RIP1-dependnt pathway, stimulate the expression of IFNbeta and IFNalpha genes.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--